Scientists move to commercialize new isotope production method

02/22/2012 | Reuters

Researchers at the TRIUMF laboratory in Vancouver, British Columbia, are in talks with several companies, including Cardinal Health, Covidien, GE Healthcare, Lantheus Medical Imaging and Nordion, over the business potential of producing the technetium-99m medical isotope using a cyclotron. The process utilizes molybdenum-100 and eliminates the need for a nuclear reactor.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC